Etsuko Miyagi
Overview
Explore the profile of Etsuko Miyagi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
222
Citations
1513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ogawara Y, Yokota N, Yamada Y, Arakawa N, Sakamaki K, Kobayashi H, et al.
J Obstet Gynaecol Res
. 2025 Feb;
51(2):e16241.
PMID: 39971476
Aim: Tissue factor pathway inhibitor 2 (TFPI2) is a preoperative biomarker that was developed to discriminate ovarian benign tumors from cancer and is covered by health insurance in Japan. The...
2.
Tsuchiya N, Imai Y, Cho T, Ogawara Y, Mizushima T, Takase H, et al.
Cureus
. 2025 Feb;
17(1):e76849.
PMID: 39901995
Primary ovarian angiosarcoma is an extremely rare malignant soft tissue tumor that arises from the vascular endothelium, with a limited number of reports. It has no specific symptoms, and it...
3.
A mouse model of deep vein thrombosis by inferior vena cava hypoperfusion using ameroid constrictors
Tadokoro H, Ota Y, Uomoto M, Koizume S, Sato S, Nakamura Y, et al.
Sci Rep
. 2025 Jan;
15(1):928.
PMID: 39762377
Traditional mouse models for deep vein thrombosis (DVT), frequently utilized in research focused on cancer-associated thrombosis (CAT), reliably induce thrombus formation by obstructing blood flow (BF) in the inferior vena...
4.
Tanoshima M, Tanoshima R, Takase H, Yamamoto D, Aoki S, Sakakibara H, et al.
Congenit Anom (Kyoto)
. 2025 Jan;
65(1):e70002.
PMID: 39743222
Turner syndrome is a chromosomal disorder, characterized by the partial or total deletion of one X chromosome, resulting in various karyotypes that presumably lead to different phenotypes. However, most studies...
5.
Sawai M, Shindo R, Nakanishi S, Obata S, Miyagi E, Aoki S
J Obstet Gynaecol Res
. 2024 Nov;
51(1):e16174.
PMID: 39614594
Aim: The occiput posterior (OP) position is the most common fetal malposition associated with poorer maternal outcomes compared to the occiput anterior (OA) position. However, there are no equivalent reports...
6.
Ito H, Yokoyama Y, Kyo S, Mandai M, Kosaka K, Kobayashi H, et al.
BMC Cancer
. 2024 Nov;
24(1):1360.
PMID: 39511580
Objective: To investigate the efficacy and safety of robot-assisted radical hysterectomy (RARH) as a minimally invasive procedure in patients with cervical cancer that is curable by surgery. Materials And Methods:...
7.
Ushio E, Mizushima T, Sukegawa A, Saigusa Y, Kurasawa K, Iwata A, et al.
J Int Med Res
. 2024 Nov;
52(10):3000605241285548.
PMID: 39495189
Objective: Cervical cancer screening rates are low in Japan. Therefore, when a woman is pregnant, this is a good opportunity to visit an obstetrics and gynecology clinic to have cervical...
8.
Crucial immunological roles of the invasion front in innate and adaptive immunity in cervical cancer
Hirahara Y, Shimizu K, Yamasaki S, Iyoda T, Ueda S, Sato S, et al.
Br J Cancer
. 2024 Oct;
131(11):1762-1774.
PMID: 39472714
Background: The immunostimulatory actions of innate and adaptive immune responses play a crucial role in the cancer-immunity cycle. Although cervical cancer (CC) exhibits a high recurrence rate, the relation with...
9.
Ota Y, Uomoto M, Koizume S, Sato S, Hoshino D, Yoshihara M, et al.
Biochem Biophys Res Commun
. 2024 Oct;
736:150890.
PMID: 39461010
Tissue factor pathway inhibitor-2 (TFPI2) is a Kunitz-type serine protease inhibitor and an ovarian clear cell carcinoma (CCC) biomarker. TFPI2 is expressed in several cancers and exerts tumor-suppressive effects; however,...
10.
Ikeda S, Ueda Y, Yagi A, Mizushima T, Sukegawa A, Kudoh R, et al.
Cancer Sci
. 2024 Oct;
116(1):226-232.
PMID: 39460387
An increase in cervical cancer incidence has been reported in Japan. The Ministry of Health, Labor, and Welfare of Japan has resumed the active recommendation of regular HPV vaccines in...